Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn

The companies are aiming to develop MGDs for targets across oncology and immunology

- PMLiVE

AstraZeneca/Daiichi Sankyo survey reveals breast cancer misconceptions in Europe

The questionnaire gathered insights from 7,750 adults across five countries

- PMLiVE

UK drug repurposing study identifies several potential dementia treatments

An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

- PMLiVE

Creating and sustaining university biotech spin-outs

Part 1: Driving the future economy

- PMLiVE

Health Awareness: The Power and Pitfalls of Social Media

Since the creation of the first social media site in 1997 [1], the use of various social media platforms has increased exponentially. As of October 2023, there were 4.95 billion...

Mednet

Recreating the Onsite Experience with the Right Tools – Building Company Culture Virtually

Distance shouldn't hinder collaboration! This video explores how the right technology can bridge the physical gap and recreate the vibrant atmosphere of an in-office environment for your remote team in...

Impetus Digital

- PMLiVE

WHO urges US to ‘reconsider’ withdrawal from global health organisation

President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

- PMLiVE

Takeda and EU Innovative Health Initiative launch Crohn’s disease prevention study

Approximately three million people in Europe are affected by inflammatory bowel disease

- PMLiVE

LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab

The drug was approved by the EC last year to treat nasopharyngeal and oesophageal cancer

- PMLiVE

Unlocking innovation: how generative AI and data are reshaping healthcare marketing

By Will Reese

- PMLiVE

Impactful Advances in Aesthetic Medicine

Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to...

Medscape Education

- PMLiVE

Sanofi’s Sarclisa granted EC approval to treat newly diagnosed multiple myeloma

Approximately 46,000 cases of the disease are expected to be diagnosed in Europe in 2025

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links